Kevin Koch, the President and CEO of Edgewise Therapeutics , Inc. (NASDAQ:EWTX), a biotechnology company with a market capitalization of $2.5 billion, recently executed a series of stock transactions, ...

Russell Alan J, the Chief Scientific Officer of Edgewise Therapeutics , Inc. (NASDAQ:EWTX), executed a series of stock transactions recently, as detailed in a recent SEC filing. On February 5 and 6, ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Prolonged exposure to microgravity in space weakens the heart muscle and disrupts the heart’s rhythm, Johns Hopkins ...

Maturation and functionality of cardiac cell types were determined by several criteria, including contractile force and relaxations measured by analyzing pole deflection, well-defined sarcomere ...

Females with hypertrophic cardiomyopathy present at a more advanced stage of the disease and have a higher risk of heart failure and death. The factors behind these differences are unclear. We aimed ...

Robert Blaustein, M.D., Ph.D., joins the Company as Chief Development Officer, responsible for leading EDG-7500, a novel cardiac sarcomere modulator in Phase 2 development, as well as the ...

A heart surgeon has revealed the simple at-home test that could reveal the symptoms of one of Britain's biggest killers. In a clip posted to TikTok, US-based cardiothoracic surgeon Dr Jeremy ...

Bradycardia refers to a resting heart rate that is slower than usual. A heart rate of fewer than 60 beats per minute (bpm) may indicate an underlying health issue, but this is not always the case.